Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachin Kamal-Bahl

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Health Affairs (Project Hope)|March 9, 2004
How do incentive-based formularies influence drug selection and spending for hypertension?Sachin Kamal-Bahl, Becky Briesacher
The American Journal of Managed Care|May 5, 2021
A practical path forward to more patient-centered value assessmentSachin Kamal-Bahl, Bryan Luce
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Financing a Cure for Diabetes in a Multipayer EnvironmentAnirban Basu, Prasun Subedi, Sachin Kamal-Bahl
Archives of Pediatrics & Adolescent Medicine|October 4, 2002
Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic reviewSachin Kamal-Bahl, Jalpa Doshi, James Campbell
American Heart Journal|July 1, 2008
Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004Heli Ghandehari, Sachin Kamal-Bahl, Nathan D Wong
Clinicoeconomics and Outcomes Research : CEOR|August 20, 2024
Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with SchizophreniaChristopher Zacker, Justin T Puckett, Sachin Kamal-Bahl
Current Medical Research and Opinion|April 17, 2025
Incremental healthcare costs among patients experiencing adverse events on oral antipsychotics: a real-world analysis of U.S. Medicare beneficiaries with schizophreniaChristopher Zacker, Justin T Puckett, Sachin Kamal-Bahl
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness AnalysisLouis P Garrison, Sachin Kamal-Bahl, Adrian Towse
The American Journal of Geriatric Pharmacotherapy|November 1, 2005
National trends in and predictors of propoxyphene use in community-dwelling older adultsSachin Kamal-Bahl, Bruce C Stuart, Mark H Beers
Clinical Therapeutics|February 27, 2009
Patients' experiences of niacin-induced flushing in clinical practice: a structured telephone interviewSachin Kamal-Bahl, Douglas J Watson, Baishali M Ambegaonkar
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Health Affairs (Project Hope)|March 9, 2004
How do incentive-based formularies influence drug selection and spending for hypertension?Sachin Kamal-Bahl, Becky Briesacher
The American Journal of Managed Care|May 5, 2021
A practical path forward to more patient-centered value assessmentSachin Kamal-Bahl, Bryan Luce
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Financing a Cure for Diabetes in a Multipayer EnvironmentAnirban Basu, Prasun Subedi, Sachin Kamal-Bahl
Archives of Pediatrics & Adolescent Medicine|October 4, 2002
Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic reviewSachin Kamal-Bahl, Jalpa Doshi, James Campbell
American Heart Journal|July 1, 2008
Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004Heli Ghandehari, Sachin Kamal-Bahl, Nathan D Wong
Clinicoeconomics and Outcomes Research : CEOR|August 20, 2024
Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with SchizophreniaChristopher Zacker, Justin T Puckett, Sachin Kamal-Bahl
Current Medical Research and Opinion|April 17, 2025
Incremental healthcare costs among patients experiencing adverse events on oral antipsychotics: a real-world analysis of U.S. Medicare beneficiaries with schizophreniaChristopher Zacker, Justin T Puckett, Sachin Kamal-Bahl
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness AnalysisLouis P Garrison, Sachin Kamal-Bahl, Adrian Towse
The American Journal of Geriatric Pharmacotherapy|November 1, 2005
National trends in and predictors of propoxyphene use in community-dwelling older adultsSachin Kamal-Bahl, Bruce C Stuart, Mark H Beers
Clinical Therapeutics|February 27, 2009
Patients' experiences of niacin-induced flushing in clinical practice: a structured telephone interviewSachin Kamal-Bahl, Douglas J Watson, Baishali M Ambegaonkar
Pageof 4